TXG
Price:
$34.755
Market Cap:
$4.41B
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell s...[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2019-09-12
Stock Exchange
NASDAQ
Ticker
TXG
According to 10x Genomics, Inc.’s latest financial reports and current stock price. The company's current ROE is -2.86%. This represents a change of 319.36% compared to the average of -0.68% of the last 4 quarters.
The mean historical ROE of 10x Genomics, Inc. over the last ten years is -11.82%. The current -2.86% ROE has changed -75.81% with respect to the historical average. Over the past ten years (40 quarters), TXG's ROE was at its highest in in the December 2018 quarter at 34.33%. The ROE was at its lowest in in the June 2019 quarter at -71.12%.
Average
-11.82%
Median
-7.44%
Minimum
-73.43%
Maximum
51.13%
Discovering the peaks and valleys of 10x Genomics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 887.12%
Maximum Annual ROE = 51.13%
Minimum Annual Increase = -114.55%
Minimum Annual ROE = -73.43%
| Year | ROE | Change |
|---|---|---|
| 2025 | -5.47% | -78.74% |
| 2024 | -25.72% | -25.29% |
| 2023 | -34.42% | 67.09% |
| 2022 | -20.60% | 189.29% |
| 2021 | -7.12% | -90.30% |
| 2020 | -73.43% | 887.12% |
| 2019 | -7.44% | -114.55% |
| 2018 | 51.13% | 206.62% |
The current ROE of 10x Genomics, Inc. (TXG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-21.87%
5-year avg
-18.67%
10-year avg
-11.82%
10x Genomics, Inc.’s ROE is greater than Schrödinger, Inc. (-30.85%), less than Progyny, Inc. (13.34%), less than Guardian Pharmacy Services, Inc. (27.21%), greater than Teladoc Health, Inc. (-12.37%), greater than Omada Health (-2.81%), greater than Janux Therapeutics, Inc. (-11.85%), less than Omnicell, Inc. (1.64%), greater than Sionna Therapeutics, Inc. (-27.31%), greater than Nuvation Bio Inc. (-44.10%), greater than Certara, Inc. (-1.43%),
| Company | ROE | Market cap |
|---|---|---|
| -30.85% | $1.18B | |
| 13.34% | $2.04B | |
| 27.21% | $2.69B | |
| -12.37% | $1.46B | |
| -2.81% | $1.05B | |
| -11.85% | $867.20M | |
| 1.64% | $1.78B | |
| -27.31% | $1.68B | |
| -44.10% | $1.93B | |
| -1.43% | $861.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 10x Genomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 10x Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is 10x Genomics, Inc.'s ROE?
How is the ROE calculated for 10x Genomics, Inc. (TXG)?
What is the highest ROE for 10x Genomics, Inc. (TXG)?
What is the 3-year average ROE for 10x Genomics, Inc. (TXG)?
What is the 5-year average ROE for 10x Genomics, Inc. (TXG)?
How does the current ROE for 10x Genomics, Inc. (TXG) compare to its historical average?